Soresi M, Giannitrapani L. Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2024; 30(30): 3541-3547 [PMID: 39193573 DOI: 10.3748/wjg.v30.i30.3541]
Please LOGIN to submit a new comment.